Can a California resident get peptides by telehealth?
Business and Professions Code section 2290.5 defines telehealth to include synchronous interactions and asynchronous store and forward transfers, requires the provider to obtain and document verbal or written consent to telehealth, and applies the same standard of care as in-person practice. Section 2242 makes it unprofessional conduct to prescribe a dangerous drug without an appropriate prior examination and medical indication, but expressly states that the exam does not require a synchronous interaction and can be achieved through telehealth, including a self-screening tool or questionnaire, if the licensee complies with the standard of care. The prescriber must hold a California license; California does not offer an out-of-state telehealth registration for physicians. Peptides in this database are not controlled substances, so federal Ryan Haight limits do not apply to them. [6] [7] [11]
How does the California pharmacy board treat compounding?
| Board | California State Board of Pharmacy |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The California State Board of Pharmacy regulates compounding under the Pharmacy Law (Business and Professions Code section 4000 and following) and Title 16 of the California Code of Regulations, sections 1735 (nonsterile) and 1736 (sterile) series, which the Board comprehensively rewrote in 2025 to align with USP chapters 795 and 797. California follows the federal 503A bulks framework for which substances may be compounded, but sets a stricter standard on copies: under 16 CCR 1735.1 and 1736.1 a compounded drug is essentially a copy of a commercially available product unless a change for an identified patient produces a clinically significant difference that the pharmacist verifies and documents, and the California rule does not treat a different strength or route alone as enough. Out-of-state pharmacies shipping into California must hold a nonresident pharmacy license under section 4112, and those shipping sterile compounded products (which includes injectable peptides) also need a nonresident sterile compounding license under section 4127.2. The Board's approved-regulations page lists the rewrite as one package (Compounded Drug Preparations: repeal and replacement of 16 CCR 1735 and following, new articles 1736, 1737, and 1738), adopted by the Board March 26, 2025, approved by the Office of Administrative Law June 19, 2025, and effective October 1, 2025; the page shows no separate earlier effective date for the essentially-a-copy provisions. [1] [2] [3] [4] [5] [8] [9] [12]
Can you get compounded GLP-1s in California?
Branded Wegovy, Zepbound, Ozempic, and Mounjaro are available from California pharmacies, and California's asynchronous telehealth rules make branded prescriptions easy to obtain remotely. Compounded semaglutide and tirzepatide are more restricted in California than federal law alone requires: beyond the end of the FDA shortage allowances in 2025, California pharmacists must document a clinically significant difference for the individual patient before compounding a GLP-1 that matches a commercial product, and a lower price is not a qualifying reason. The Board's rules allow shortage-based compounding again only if the drug returns to the FDA or ASHP shortage list. [3] [7] [15]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in California?
Verified access options
Prescriber licensed in California, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in California. Asynchronous (questionnaire or messaging) prescribing is permitted when it meets the standard of care.
Pharmacy licensed or registered with the California State Board of Pharmacy
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in California
Is it legal to buy research peptides in California?
California's Sherman Food, Drug, and Cosmetic Law bars selling, delivering, or giving away any new drug in California unless it has federal approval or a California approval (Health and Safety Code section 111550). "Research use only" peptides sold for human use are unapproved new drugs under both the Sherman Law and federal law, and only licensed pharmacies may dispense prescription drugs to California patients. [10] [16]
Peptide-specific notes for California
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including after an asynchronous questionnaire-based telehealth exam under Business and Professions Code section 2242. Compounded semaglutide requires a documented clinically significant difference for the patient under California's 2025 essentially-a-copy rules, a stricter bar than the federal patient-specific exception. [3] [7] [15] |
| Tirzepatide | Available branded by prescription. Compounded tirzepatide faces the same California clinically significant difference requirement, and any compounded vial shipped from outside California must come from a pharmacy holding a nonresident sterile compounding license under section 4127.2. [3] [9] |
| BPC-157 | Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. California pharmacies apply the federal bulks test plus the Board's rewritten compounding standards, and the Board has not issued a BPC-157 specific rule. [2] [13] [14] |
Compare: Semaglutide vs tirzepatide.
Frequently asked questions
Can I get a GLP-1 prescription in California through an online questionnaire?
Yes, if the prescriber meets the standard of care. California Business and Professions Code section 2242 says an appropriate prior exam does not require a synchronous interaction and can be done through telehealth, including a self-screening tool or questionnaire. The prescriber must be California-licensed and must document your consent to telehealth under section 2290.5. [6] [7]
Why is compounded semaglutide harder to get in California than in other states?
California's 2025 compounding regulations treat a compounded drug as essentially a copy of a commercial product unless a change made for you produces a clinically significant difference that the pharmacist verifies and documents. That is stricter than the federal standard, and price is not a valid reason. [3] [15]
What licenses does an out-of-state pharmacy need to ship injectable peptides to California?
Two. It needs a nonresident pharmacy license under Business and Professions Code section 4112, and because injectable peptides are sterile compounded products it also needs a nonresident sterile compounding license under section 4127.2. Verify both on the Board of Pharmacy license lookup. [1] [8] [9]
Can a California pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [2] [13] [14]
Is it legal to buy research peptides online in California?
Not for human use. Health and Safety Code section 111550 bars selling or delivering an unapproved new drug in California, and research-labeled peptides sold for injection are unapproved new drugs under both state and federal law. [10] [16]
From the blog
- Can you get a GLP-1 through telehealth in your state?
Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with ten state examples.
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]California State Board of Pharmacy
- [2]California State Board of Pharmacy: laws and regulations (Pharmacy Law and 16 CCR compounding sections)
- [3]California Board of Pharmacy: regulation text, compounding in licensed pharmacies (16 CCR 1735 and following, including the essentially-a-copy definition)
- [4]California State Board of Pharmacy: approved regulations (Compounded Drug Preparations, effective October 1, 2025; OAL approval June 19, 2025), accessed 2026-09-22
- [5]California State Board of Pharmacy: compounding policy statement (June 19, 2025 notice of approval, regulations effective October 1, 2025), accessed 2026-09-22
- [6]California Business and Professions Code section 2290.5, Telehealth
- [7]California Business and Professions Code section 2242, Prescribing without an appropriate prior examination
- [8]California Business and Professions Code section 4112, Nonresident pharmacy license
- [9]California Business and Professions Code section 4127.2, Nonresident sterile compounding pharmacy license
- [10]California Health and Safety Code section 111550, New drugs (Sherman Food, Drug, and Cosmetic Law)
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in California?. https://peptideagent.ai/legal/california- HTML link
<a href="https://peptideagent.ai/legal/california">Are peptides legal in California?</a>, PeptideAgent, updated September 22, 2026.